MX1 - Quarterly Activities Report & Appendix 4C
| Stock | Micro-X Ltd (MX1.ASX) |
|---|---|
| Release Time | 31 Jul 2026, 5:31 p.m. |
| Price Sensitive | Yes |
Micro-X Ltd Quarterly Activities Report & Appendix 4C
- Head CT human imaging pilot study commenced at Royal Melbourne Hospital
- $1.5M received in Head CT project milestone payments
- $1.6M ARPA-H milestone payment on Full Body CT critical design review
- Cash balance of $3.1M as at 30 June 2026
Micro-X Ltd, an Australian hi-tech company, released its Quarterly Activities Report and Appendix 4C for the quarter ended 30 June 2026. The report highlights significant operational progress, including the commencement of a Head CT human imaging pilot study at the Royal Melbourne Hospital and receiving $1.5M in milestone payments under Australian Government-funded programs. Commercial activities saw a visit from Malaysian Ministry of Health representatives and the showcasing of Rover Plus at WHX Miami and the National Athletic Trainers' Association conference. Financially, the company reported a cash balance of $3.1M as at 30 June 2026, with net cash used in operating activities of $3.2M for the quarter. The company expects to receive $8.1M in contracted development program receipts from FY27 onwards, subject to meeting development milestones.
Micro-X expects approximately $2 million of the net FY26 Research and Development Tax Incentive rebate to flow through operating activities in October 2026.
Micro-X expects its net operating cash flows to improve in coming quarters, with plans to finalize a convertible note placement to institutional and sophisticated investors.